MedStar Heart and Vascular Institute Researchers Describe Recent Advances in Heart Failure (Changes in health insurance status and mortality in patients with acute heart failure): Heart Disorders and Diseases – Heart Failure

2025 AUG 07 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Fresh data on heart failure are presented in a new report. According to news reporting originating from the MedStar Heart and Vascular Institute by NewsRx correspondents, research stated, “Health insurance changes (HIC) can lead to coverage gaps, alter the continuity of care, potentially affecting clinical outcomes; Heart Failure (HF) is a leading contributor to hospital readmissions in the U.S.”

The news journalists obtained a quote from the research from MedStar Heart and Vascular Institute: “We analyzed the relationship between HIC, readmission costs and mortality in patients with HF after a recent hospitalization. We used data from the 2019 National Readmission Database to analyze 30-day re-admission incidence, costs and mortality in hospitalized HF patients in relation to HIC. Among 569,714 acute HF admissions, 4.2 % of patients (n = 4811) experienced HIC within 30 days; HIC were associated with younger age, more comorbidities, and Medicaid coverage. HIC were associated with higher readmission mortality, longer hospitalizations and increased hospital costs.”

According to the news reporters, the research concluded: “HIC in high-risk HF patients are associated with worse clinical outcomes and higher cost burden, highlighting the need for efforts aimed at preserving continuity of coverage in this population.”

For more information on this research see: Changes in health insurance status and mortality in patients with acute heart failure. American Heart Journal Plus, 2025,56():100567. The publisher for American Heart Journal Plus is Elsevier.

A free version of this journal article is available at https://doi.org/10.1016/j.ahjo.2025.100567.

Our news editors report that additional information may be obtained by contacting Federico Viganego, MedStar Heart and Vascular Institute, Baltimore, MD, United States of America. Additional authors for this research include Mark K. Meiselbach, Michael G. Fradley, Samer S. Najjar.

(Our reports deliver fact-based news of research and discoveries from around the world.)